header logo image


Page 225«..1020..224225226227..230240..»

New forensic programs investigate deaths of unclaimed dogs and cats – American Veterinary Medical Association

February 7th, 2021 3:53 am

As the field of veterinary forensics continues to develop, a forensic pathologist at the University of Florida College of Veterinary Medicine has created two programs, A Dog Has No Name and A Cat Has No Name, to investigate the deaths of unclaimed dogs and cats. At the same time, the International Veterinary Forensic Sciences Association has released standards for postmortem examinations.

Dr. Adam Stern, a forensic pathologist at the UF veterinary college, created the new programs to investigate the deaths of unclaimed animals in the Florida area. Since the programs start in 2019, more than 150 dogs and cats have been examined, including some from across the U.S.

Were doing a long-term mortality study, looking at these animals and figuring out what is going on with them, Dr. Stern said. Theyre not all being hit by cars, and we are finding some interesting stuff. We are documenting it, including some suspicious deaths that we report to law enforcement.

A Dog Has No Name and A Cat Has No Name are a collaboration between law enforcement and forensic specialists at Floridas Maples Center for Forensic Medicine.

One of the goals of the programs is to find the owners of the unclaimed animals.

We have reunited some dogs to the owners for closure, and they were appreciative for what we did. Its doing a good deed, at the end of the day. Some of these people are going to be searching for a dog forever. We want to provide closure, Dr. Stern said. As a pathologist, I deal with end of life, that is all I do. This is a positive effect, the closure is positive.

Dr. Stern said the programs are also being used to train residents and students on death investigations. Most case investigations include a traditional autopsy and a gross examination with a postmortem CT scan and radiography.

Anything we need to do, we will do, Dr. Stern said. If we have an owner that thinks it may be their cat, we have the capabilities to do a DNA comparison. We are also banking tissues from every case. We have reports from every case that include tissues, so we can go back and do retrospectives.

Dr. Stern is also working to make other veterinarians across the U.S. aware of what the programs do and is currently willing to accept samples of unowned, stray, or street animals from anywhere in the U.S. The services are free of charge.

The guidelines on postmortem examinations, released in December 2020, include clinical best practices for identifying, documenting, and preserving evidence in crimes when animals are involved and there is suspected abuse.

The guidelines (PDF) were created by the International Veterinary Forensic Sciences Association.

As board-certified pathologists and leaders in the field of veterinary forensic pathology, it is our duty to develop a set of standards to provide a framework to ensure that forensic postmortem examinations are performed to a minimum standard, Dr. Stern said.

The standards include some of the following language related to how a veterinarian should perform a postmortem examination:

Correction: An earlier version of this article incorrectly stated the organization that created and published the guidelines on postmortem examinations. International Veterinary Forensic Sciences Association created the guidelines.

Continued here:
New forensic programs investigate deaths of unclaimed dogs and cats - American Veterinary Medical Association

Read More...

American College of Veterinary Anesthesia and Analgesia – American Veterinary Medical Association

February 7th, 2021 3:53 am

Event

Virtual business meeting, Sept. 26, 2020

Career Achievement AwardDr. Peter Pascoe, Davis, California. A 1975 veterinary graduate of the University of Liverpool in England, Dr. Pascoe is a professor emeritus of surgical and radiological sciences at the University of California-Davis. He helped launch the journal Veterinary Anesthesia and Analgesia and served as its editor until 2013, remaining on the editorial board. Dr. Pascoe is a diplomate of the ACVAA and the European College of Veterinary Anaesthesia and Analgesia.

Presidents AwardDrs. John Ludders (Washington State 77), Spokane, Washington, and Pauline Wong (California-Davis 75), San Diego, were recognized for their work in creating and maintaining the ACVAA Listservs. A diplomate of the ACVAA, Dr. Ludders is a professor emeritus in the section of anesthesiology at Cornell University College of Veterinary Medicine. Dr. Wong served as a lecturer and was a consulting anesthesiologist at the University of California-Davis School of Veterinary Medicine prior to retirement. She is a diplomate of the ACVAA.

Lisa Ann Bourazak, Highland Park, IllinoisAngie Lagos Carvajal, Calgary, AlbertaUrshulaa Dholakia, New Hyde Park, New YorkBen Gingold, New York CityAlison Jaeger, Davis, CaliforniaEmma Kate Johnson, Roseville Chase, AustraliaGenevive Caterina Luca, San Jose, CaliforniaMatthew Milloway, ChicagoMelissa Murdock, PhiladelphiaTania Perez Jimenez, Pullman, WashingtonFrdrik Rousseau-Blass, Sainte-Hyacinthe, QuebecDanielle Eliese Strahl-Heldreth, Champaign, IllinoisChristopher Thibault, Lansing, MichiganEduardo Uquillas, Elderslie, AustraliaKelley Varner, Columbia, Missouri

The association discussed problems caused by the ongoing COVID-19 pandemic, including the postponement of the 2020 certifying examination, which was subsequently held remotely in October, and the effect on residency programs and resident training.

Drs. Colin Dunlop, Gladesville, Australia, president; Kurt Grimm, Conifer, Colorado, president-elect; Lynne Kushner, Portsmouth, Rhode Island, executive secretary; Berit Fischer, Lebanon, New Jersey, chair of the board of directors; and Christine Egger, Saskatoon, Saskatchewan, immediate past president

View post:
American College of Veterinary Anesthesia and Analgesia - American Veterinary Medical Association

Read More...

Veterinary Medicine Market to Witness Huge Growth by 2026 | Bayer Animal Health, Merck Animal Health, Virbac – NeighborWebSJ

February 7th, 2021 3:53 am

Latest Study on Industrial Growth ofGlobal Veterinary Medicine Market2019-2025. A detailed study accumulated to offerLatest insights about acute features of the Veterinary Medicine market. The report contains different market predictions related to market size, revenue, production, CAGR, Consumption, gross margin, price, and other substantial factors. While emphasizing the key driving and restraining forces for this market, the report also offers a complete study of the future trends and developments of the market. It also examines the role of the leading market players involved in the industry including their corporate overview, financial summary and SWOT analysis.

The Major Players Covered in this Report: Boehringer Ingelheim, Zoetis, Elanco Animal Health, Bayer Animal Health, Merck Animal Health, Virbac, Dechra Veterinary Products, Ceva, Vetoquinol, Meiji, Ouro Fino Saude, Animalcare Group & Parnell

Veterinary Medicine Market Study guarantees you to remain / stay advised higher than your competition. With Structured tables and figures examining the Veterinary Medicine, the research document provides you a leading product, submarkets, revenue size and forecast to 2025. Comparatively is also classifies emerging as well as leaders in the industry.Click To get SAMPLE PDF (Including Full TOC, Table & Figures)

Global Veterinary Medicine market size will increase to xx Million US$ by 2025, from xx Million US$ in 2018, at a CAGR of xx% during the forecast period. In this study, 2018 has been considered as the base year and 2019 to 2025 as the forecast period to estimate the market size for Veterinary Medicine.

This report researches the worldwide Veterinary Medicine market size (value, capacity, production and consumption) in key regions like United States, Europe, Asia Pacific (China, Japan) and other regions.This study categorizes the global Veterinary Medicine breakdown data by manufacturers, region, type and application, also analyzes the market status, market share, growth rate, future trends, market drivers, opportunities and challenges, risks and entry barriers, sales channels, distributors and Porters Five Forces Analysis.

This study also covers company profiling, specifications and product picture, sales, market share and contact information of various regional, international and local vendors of Global Veterinary Medicine Market. The market opposition is frequently developing greater with the rise in scientific innovation and M&A activities in the industry. Additionally, many local and regional vendors are offering specific application products for varied end-users. The new merchant applicants in the market are finding it hard to compete with the international vendors based on reliability, quality and modernism in technology.

Global Veterinary Medicine market size will increase to xx Million US$ by 2025, from xx Million US$ in 2018, at a CAGR of xx% during the forecast period. In this study, 2018 has been considered as the base year and 2019 to 2025 as the forecast period to estimate the market size for Veterinary Medicine.

This report researches the worldwide Veterinary Medicine market size (value, capacity, production and consumption) in key regions like United States, Europe, Asia Pacific (China, Japan) and other regions.This study categorizes the global Veterinary Medicine breakdown data by manufacturers, region, type and application, also analyzes the market status, market share, growth rate, future trends, market drivers, opportunities and challenges, risks and entry barriers, sales channels, distributors and Porters Five Forces Analysis.

Read Detailed Index of full Research Study at @https://www.htfmarketreport.com/reports/1529343-global-veterinary-medicine-market-2

The titled segments and sub-section of the market are illuminated below:

In-depth analysis of Global Veterinary Medicine market segments by Types: , Oral, Injection & Other

Detailed analysis of Global Veterinary Medicine market segments by Applications: Companion Animals & Livestock Animals

Major Key Players of the Market: Boehringer Ingelheim, Zoetis, Elanco Animal Health, Bayer Animal Health, Merck Animal Health, Virbac, Dechra Veterinary Products, Ceva, Vetoquinol, Meiji, Ouro Fino Saude, Animalcare Group & Parnell

Regional Analysis for Global Veterinary Medicine Market: APAC (Japan, China, South Korea, Australia, India, and Rest of APAC; Rest of APAC is further segmented into Malaysia, Singapore, Indonesia, Thailand, New Zealand, Vietnam, and Sri Lanka) Europe (Germany, UK, France, Spain, Italy, Russia, Rest of Europe; Rest of Europe is further segmented into Belgium, Denmark, Austria, Norway, Sweden, The Netherlands, Poland, Czech Republic, Slovakia, Hungary, and Romania) North America (U.S., Canada, and Mexico) South America (Brazil, Chile, Argentina, Rest of South America) MEA (Saudi Arabia, UAE, South Africa)

Furthermore, the years considered for the study are as follows:Historical year 2014-2019Base year 2019Forecast period** 2020 to 2025 [** unless otherwise stated]

**Moreover, it will also include the opportunities available in micro markets for stakeholders to invest, detailed analysis of competitive landscape and product services of key players.

Buy Latest COVID Impact Study of Global Veterinary Medicine Market @https://www.htfmarketreport.com/buy-now?format=1&report=1529343

Guidance of the Global Veterinary Medicine market report:

Detailed considerate of Veterinary Medicine market-particular drivers, Trends, constraints, Restraints, Opportunities and major micro markets. Comprehensive valuation of all prospects and threat in the Global Veterinary Medicine market. In depth study of industry strategies for growth of the Veterinary Medicine market-leading players. Veterinary Medicine market latest innovations and major procedures. Favorable dip inside Vigorous high-tech and market latest trends remarkable the Market. Conclusive study about the growth conspiracy of Veterinary Medicine market for forthcoming years.

What to Expect from this Report On Veterinary Medicine Market:

1. A comprehensive summary of several area distributions and the summary types of popular products in the Veterinary Medicine Market.2. You can fix up the growing databases for your industry when you have info on the cost of the production, cost of the products, and cost of the production for the next future years.3. Thorough Evaluation the break-in for new companies who want to enter the Veterinary Medicine Market.4. Exactly how do the most important companies and mid-level companies make income within the Market?5. Complete research on the overall development within the Veterinary Medicine Market that helps you elect the product launch and overhaul growths.

Enquire for customization in Report @https://www.htfmarketreport.com/enquiry-before-buy/1529343-global-veterinary-medicine-market-2

Detailed TOC of Veterinary Medicine Market Research Report-

Veterinary Medicine Introduction and Market Overview Veterinary Medicine Market, by Application [Companion Animals & Livestock Animals]

Veterinary Medicine Industry Chain Analysis Veterinary Medicine Market, by Type [, Oral, Injection & Other]

Industry Manufacture, Consumption, Export, Import by Regions (2014-2019) Industry Value ($) by Region (2014-2019)

Veterinary Medicine Market Status and SWOT Analysis by Regions

Major Region of Veterinary Medicine Marketi) Global Veterinary Medicine Salesii) Global Veterinary Medicine Revenue & market share Major Companies List Conclusion

Thanks for reading this article; you can also get individual chapter wise section or region wise report version like North America, Europe or Asia.

Contact US :Craig Francis (PR & Marketing Manager)HTF Market Intelligence Consulting Private LimitedUnit No. 429, Parsonage Road Edison, NJNew Jersey USA 08837Phone: +1 (206) 317 1218[emailprotected]report.com

Connect with us atLinkedIn|Facebook|Twitter

https://neighborwebsj.com/

Continued here:
Veterinary Medicine Market to Witness Huge Growth by 2026 | Bayer Animal Health, Merck Animal Health, Virbac - NeighborWebSJ

Read More...

UT’s Aligncare Program works with Knoxville organizations to help COVID-19 patient and his assistance dog on New Year’s Eve – UT Daily Beacon

February 7th, 2021 3:53 am

Every person in the world has been impacted by the COVID-19 pandemic in at least one way over the past year. Humans, however, are not the only species affected by the virus and its ability to separate families.

On New Years Eve, a Knoxville resident contracted COVID-19 and had to be hospitalized. Although he was used to having his assistance dog, Duchess, by his side at all times, he needed to find someone to take care of his beloved pet while he was treated at UT Medical Center. Luckily, a UT program was able to help.

A part of the UTs College of Veterinary Medicine, the Program for Pet Health Equity is designed to ensure that all pets have access to veterinary care.

Dr. Michael Blackwell, the director of the Program for Pet Health Equity and the Center for Behavioral Health Research in the College of Social Work, wants to be sure that all pets have healthcare readily available to them because pets are so important to families in the United States.

We are addressing a national family crisis in America, Blackwell said. Two thirds of households in America have pets and 88% of those families consider their pet a family member.

We dont have a network of healthcare that subsidizes healthcare of nonhuman members. Our work is really about addressing that national crisis. This is about more than just pets. Its about American families.

One of the ways the Program for Pet Health Equity aims to execute their mission is by using the program Aligncare, which uses veterinary social workers to help citizens find resources for their pets.

Dr. Pamela Linden, Director of Veterinary Social Work for the Aligncare program, is also passionate about finding community resources for pet-owners to use when they may not be able to afford veterinary care.

It's not unusual for people to find themselves in situations where they need assistance and there are very few organized systems to assist pet owners with life circumstances, Linden said.

People end up being unexpectedly hospitalized, people get sick, people move, people pass away and they have pets.

These are all life situations that have the potential to separate families or people from their beloved pets. So, we at Aligncare are very interested in helping communities create systems that are planful to help keep families together, Linden said.

This organized system is what came to the rescue when Duchess needed help on New Years Eve. Not only did Duchess need a place to stay, but she also has cancer, so she needed someone to properly administer her medication while she was separated from her owner.

When Dr. Linden heard about the situation, she immediately contacted Knoxville Animal Control, who were quick to help.

We have the relationship with the client, so the client reached out and then our partners in Knoxville really stepped up to the plate and made sure that this family got what they needed to stay together, Linden said.

Their idea was to get Duchess to Young Williams Animal Center, but seeing as it was a holiday, the center was closed. After working it out with UT Medical Center, they eventually were able to contact the shelter who watched Duchess over the long weekend. Also, a key player in the events was Central Veterinary Hospital, who ensured that Duchesss medication was not interrupted.

After the holiday weekend, the client recovered and was reunited with Duchess. The events on New Years Eve are a prime example of how a community can work together to ensure that citizens have the proper resources to care for their animals.

The best way to say it is everybody came together and went above and beyond what would normally be expected, and the client is so grateful for the assistance of everyone who came together to help him and Dutchess, Linden said.

Its a wonderful story because not only does it shine a light on Aligncare, it shines a light on Knoxville, because there were multiple partners involved and to see people step up to the plate and address a critical need for one of our citizens is what we want to see going on in all communities in America, Blackwell said.

Created at UT, the Veterinary Social Work program combines the principles of both social work and veterinary medicine to create a field that focuses on bridging the gap between human and animal needs. The intersection of these two disciplines is to thank for the care that Duchess and her owner received on New Years Eve.

Duchesss story is a positive reminder of the good that can come when people join forces to help each other, and its a story that people need to hear, especially right now.

We need to see the good side of America because theres so much going on in the nation, Blackwell said. We get to hear about the frontline medical workers and the frontline workers in other places, but throughout America, were still made up of a lot of compassionate, caring people, and whatever we do we need stories that remind us that that's us too a caring, compassionate nation.

Aligncare also has community sites in Las Vegas, Phoenix, Asheville, N.C. and Long Island, N.Y. They have student interns from multiple universities including UT, NYU, Stony Brook University and St. Josephs College.

Read the rest here:
UT's Aligncare Program works with Knoxville organizations to help COVID-19 patient and his assistance dog on New Year's Eve - UT Daily Beacon

Read More...

What are the odds?: 3 UC Davis students discover they were adopted from same Chinese province – WGN TV Chicago

February 7th, 2021 3:53 am

DAVIS, Calif. (KTXL) Three women studying veterinary medicine at the University of California, Davis recently discovered they have a lot more in common than an interest in helping animals.

Molly Mettler, Livvy Peterson and Jennie Furth-Jacobus are all first-year veterinary students. Theyre all left-handed and they all played volleyball in high school. They each grew up in Southern California.

In fact, Mettler and Furth-Jacobus lived just 10 minutes from each other in Los Angeles. They never met until they got to UC Davis.

But during a conversation last semester, they realized their lives are linked by a series of coincidences stretching all the way from a province in China.

We just kind of started talking and introducing ourselves and we got around to talking about how we were all adopted from China. And then we got to, like, Oh, where in China? Peterson said. And we were from the same province: in Guangdong.

And so we really bonded over that, Furth-Jacobus said.

Then we talked more about it, the details of it, Mettler added.

They were each abandoned as infants by their birth parents and placed in orphanages in Guangdong province.

From there, they were all adopted by American parents through the same adoption agency. They each pursued veterinary medicine degrees and got accepted into the prestigious program at UC Davis.

Like, what-are-the-odds kind of thing, Peterson said.

I cant wrap my head around it still, Mettler said.

And then to have us in the first year together in the same class its crazy, Furth-Jacobus said.

In the same lab group, too, Mettler added.

Oh yeah, and were in the same lab group, Furth-Jacobus agreed.

Because were divided into four different groups, Mettler said. So the chances of even just being put in the same group, too, is even slimmed down more.

During a time when lectures are given online for COVID-19 safety, the labs provide that rare space where class is conducted in-person. And thats how the friends really got to know each other.

Weve been very grateful to have in-person labs, Furth-Jacobus said.

Yeah, its something that were definitely not taking for granted, Mettler added.

Especially when we havent really gotten a lot of chances to meet a lot of our classmates. So then having something else that connects you deeper is like, you know, another step, Peterson said. So I think thats really cool.

Gratitude is also something they have in common extending to the parents who adopted them as well as to the birth parents who surrendered them.

I know that they did their best and that circumstances were just really tough, Furth-Jacobus said.

Its one of those things that was kind of meant to be, Peterson said. Like Im personally really happy that I ended up here in America with my American family that I did.

I mean, were here at UC Davis, the No. 1 vet school in the world. So Im grateful for the sacrifices that they made so that I could have a better life, Furth-Jacobus added.

Thats amazing that were here together, and weve experienced that, Mettler said.

Link:
What are the odds?: 3 UC Davis students discover they were adopted from same Chinese province - WGN TV Chicago

Read More...

Keeping the Horse’s Hindgut Happy The Horse – TheHorse.com

February 7th, 2021 3:53 am

Getting back to basics might be the key to keeping the largest portion of the horses GI tract functioning properly

Horses are powerful, athletic animals. Their digestive systems, however, are delicate compared to those of most other types of livestock. Ruminants such as cattle and sheep have multicompartment stomachs. Saliva created by chewing a cud processes food in the front half of ruminants digestive tracts. Horses, however, rely on a metabolically complex fermentation process. And because horses only have one stomach, most of that fermentation occurs in the back part or hindgut.

Despite making up the largest portion of a horses gastrointestinal (GI) tract, the hindgut, which includes the cecum and large colon (or large intestine), often receives far less attention from owners than the stomach or small intestine, says Kenneth Kopp, DVM, a consulting veterinarian based in St. Louis, Missouri.

The hindgut is about 25 gallons in a 1,000-pound horsethats huge compared to the (2-4-gallon) stomach, he says. The stomach is only 10% of the GI tract, but theres such a focus there. Billions of microorganisms, including protozoa, fungi, and bacteria, live in the hindgut. Their job is to convert carbohydrates into fatty acids and provide the horse with energy. Feed or forage might spend as much as 48 hours in the hindgut compared to a few hours or less in the small intestine.

Ideally, by the time material gets to the hindgut, water-soluble carbohydrates and easily digestible proteins are already broken down and absorbed, says Amy Biddle, PhD, assistant professor of animal science in the University of Delawares Department of Animal and Food Sciences, in Newark. The fibrous part of feed, structural carbohydrates, are passed right through the small intestine to the hindgut, where the bacteria are really good at breaking them down and converting them to energy sources that the horse can utilize.

The hindgut also absorbs short-chain fatty acids, which Biddle estimates provide at least 46% of the horses energy stores. For that and other reasons it is critical to keep those microorganisms happy and functioning properly.

Although researchers, veterinarians, and nutritionists know how critical hindgut function is to overall health, they know much less about this part of the digestive system than others. Generally, theyre unable to examine the hindgut with imaging equipment, and clinicians dont perform autopsies in horses as frequently as they do in food animals. Veterinarians can use ultrasound to see small portions of the hindgut through the abdominal wall, and they can reach the colon with a GI smart pill endoscopic camera, but visibility is still limited. For the most part, researchers look to studies in humans and other livestock species and existing equine digestive system research to help horse owners promote a healthy hindgut.

The hindgut is naturally more basic than other parts of the digestive system, says Biddle. Large grain meals and sudden diet changes can promote the growth of lactic acid producers that rapidly shift the pH level in the hindgut and can lead to lactic acidosis, a dangerous situation in which the acidity increase kills off the beneficial bacterial population.

This is why it is important to change feeds so slowly, so the microbes in the hindgut can keep up, says Biddle, and so abrupt changes do not stress the system. Especially if youre going to change to a diet higher in nonstructural carbohydrates (simple sugars and fructans, which are readily digested), it has to be introduced slowly.

Getting back to basics and simplifying meals is the best approach for maintaining a healthy hindgut. Ideally, you want to feed your horse a diet thats high in forage and low in grains, says Anthony Blikslager, DVM, PhD, Dipl. ACVS, head of the department of clinical sciences and equine surgery and gastroenterology professor at North Carolina State Universitys College of Veterinary Medicine, in Raleigh.

Horses evolved on ever-changing marginal grasslands. They were browsers that adapted to be grazers that rely on continual forage intake. This article continues in the February 2021 issue of The Horse: Your Guide to Equine Health Care. Subscribe now and get an immediate download of the issue to continue reading. Current magazine subscribers can access the digital edition here.

See the original post here:
Keeping the Horse's Hindgut Happy The Horse - TheHorse.com

Read More...

When will veterinarians get COVID-19 vaccines? – American Veterinary Medical Association

February 7th, 2021 3:53 am

The first Americans started receiving the COVID-19 vaccines in mid-December. By late January, however, many veterinarians still werent sure where they were in the line for vaccination.

The AVMA House of Delegates, during its regular winter session in early January, discussed the COVID-19 pandemic during the Veterinary Information Forum, and many delegates focused on the rollout of vaccines across the country.

The AVMA has successfully advocated for veterinarians to be among those prioritized for vaccination in federal-level guidance, but tactical decisions are made at the state, territorial, and local levelsand the situation continues to evolve.

Other delegates touched on ongoing difficulties with providing child care during the pandemic.

Dr. Cheryl Greenacre, delegate for the Association of Avian Veterinarians, started the discussion by asking what state VMAs can do to advocate so that veterinarians will be listed as health care workers able to receive COVID-19 vaccines in Phase 1a.

Dr. Jos Arce, AVMA president-elect, said the AVMA has been advocating for veterinarians to be a priority group since September. The AVMA provided comments to the National Academies of Sciences, Engineering, and Medicine on the Discussion Draft of the Preliminary Framework for Equitable Allocation of COVID-19 Vaccine. The draft was intended to inform the Centers for Disease Control and Preventions Vaccination Program Interim Playbook for Jurisdiction Operations.

In Puerto Rico, where Dr. Arce lives, the territorys veterinary association met with the territorys health department and other health associations and, later, the National Guard. Veterinarians thought they were going to be in Phase 1b, as front-line essential workers, and they were surprised to be scheduled for late 1a. Dr. Arce suggested that state VMAs should contact the state health department and join with other health professions.

Dr. Carol Ryan, Missouri delegate, said veterinarians are scheduled for Phase 1b in Missouri. As of early January, no veterinarians or veterinary staff members had been able to be immunized. She was curious whether, in other states, staff members were included with veterinarians as a priority group.

In Puerto Rico, Dr. Arce replied, everyone on the veterinary team qualifies for the same phase. Veterinarians need to provide their license to practice and a form proving that a staff member works at a veterinary hospital.

Dr. Diana Thom, Washington state delegate, said the Washington State VMA sent out a notification in early January that the state had added a catchall in Phase 1a to cover all health care workers. The WSVMA interpreted that to mean veterinarians and their teams. After the House of Delegates session, the WSVMA issued an update saying health officials subsequently told the association that veterinarians were in a later phase to be determined.

Dr. Jon Pennell, Nevada delegate, said the Nevada VMA and state veterinary board submitted a letter requesting that veterinarians be included in one of the earlier tiers for vaccination. Dr. William Grant, California delegate, said he had just heard the good news that the California Department of Public Health had designated veterinarians and veterinary staff members to be in Phase 1a.

The AVMA comments to the National Academies used the following rationale:

The AVMA has developed a downloadable poster for the back office, Fighting COVID-19 starts with you, to encourage all team members to get vaccinated as early as possible.

The AVMA also has developed a list of answers to frequently asked questions about vaccination against COVID-19.

One question is, Can practice owners require team members to be vaccinated against COVID-19 when a vaccine is available to them?

The answer states that, according to guidance from the U.S. Equal Employment Opportunity Commission: Employers may, under certain conditions, bar employees from the workplace if they refuse to get a vaccine. ... The EEOC warns, however, that this does not mean the employer may automatically terminate the employee. ... For example, the employee may be entitled to an accommodation, such as performing work remotely. ... State law may differ from federal law and may prohibit employers from requiring employees to receive a COVID-19 vaccination.

As the vaccine rollout continues, working parents at veterinary practices and elsewhere continue to juggle doing their jobs with caring for young children as many schools and day cares remain closed.

Dr. Paul Toniolli, Utah alternate delegate, said his office manager started to work from home. Hes had children come into the clinic, which is not ideal, but the building has an upstairs area. Some staff members have to stay home to watch their kids. He has stepped up the pace himself, working extra hours, and is simply being more flexible.

Dr. Lindy ONeal, Arkansas delegate, said that as her two-clinic practice is continuing with curbside service, some examination rooms are not being used. The practice allows staff members to bring children in to have a place for them to go. One of the clinics even has a napping room. Children are not allowed to come if they are under quarantine, but using the empty examination rooms has been a creative way to be flexible.

Read the rest here:
When will veterinarians get COVID-19 vaccines? - American Veterinary Medical Association

Read More...

Researchers at Ohio State University are studying COVID-19 in animals and the environment to identify future pandemic threats – WKYC.com

February 7th, 2021 3:53 am

Veterinarians, microbiologists and epidemiologists are testing pets, farm animals and wildlife to see if they can pass COVID-19 mutations to humans

COLUMBUS, Ohio While much effort is currently invested in understanding how COVID-19 (SARS-CoV-2) spreads among and infects humans, researchers at The Ohio State University are focusing on better understanding how the virus might arise and mutate in animal populations, and in turn impact humans.

Dr. Vanessa L. Hale, assistant professor of veterinary preventive medicine at The Ohio State University College of Veterinary Medicine, alongside peers from the Infectious Disease Institute and Center of Microbiome Science, is coordinating the efforts of investigators across various departments and colleges at Ohio State.

Were seeing that its not good enough to just respond to a pandemic. We need to be prepared for it in terms of strategies and logistics and understand the science behind animal to human and human to animal disease transmission, Hale said.

We spend a lot of time understanding how the disease transmits within humans, and now we are taking a step back to examine if animals can carry the virus, if they get sick and whether they can re-infect humans. Finding the answers to these questions will help predict and prevent future infections.

The University-wide program including veterinarians, microbiologists and epidemiologists is known as eSCOUT: Environmental Surveillance for COVID-19 in Ohio: Understanding Transmission. Together, these experts are testing pets, farm animals and wildlife and examining samples in the lab.

The goal is to identify whether the virus exists in different animal populations and the likelihood that those animals could harbor mutations and potentially pass COVID-19 back to humans in a new form.

Identifying SARS-CoV-2 in animals can help to start answering questions about what kinds of animals can be infected, symptomatically or asymptomatically, and if these animals can then transmit the virus to other animals or people. Environmental and animal surveillance will provide critical insights on current circulating SARS-CoV-2 strains as well as emerging mutations and spread. This monitoring is vital to help predict and prevent future outbreaks and spillover events.

eSCOUT is also involved in testing wastewater and storm water (also referred to as urban runoff) around Ohio for SARS-CoV-2. Researches say that identifying the virus in wastewater can help determine how much and what strain of virus is circulating within a population. Viral spikes in wastewater also allow early detection of outbreaks.

Pandemics really highlight one health, which is human health, animal health and environmental health. Veterinarians, as well as environmental microbiologists, wildlife biologists and epidemiologists are really essential to understanding the whole dynamic of a pandemic, Hale said.

Environmental surveillance has been used in the past to identify new strains of the flu that could potentially spillover from animals to humans. Its likely that this same kind of surveillance will play a critical role in mitigating the COVID-19 pandemic as well as long-term preventive efforts.

The rest is here:
Researchers at Ohio State University are studying COVID-19 in animals and the environment to identify future pandemic threats - WKYC.com

Read More...

Appointments, honors and activities – Purdue News Service

February 7th, 2021 3:53 am

Thanos Tzempelikos, professor in the Lyles School of Civil Engineering, has received the prestigious Leon Gaster Award from the Society of Light and Lighting as a co-author of the paper, "Cross-validation and Robustness of Daylight Glare Metrics." This award is presented annually, naming the best paper of the year concerned with lighting applications. The award was presented at the societys Annual Awards evening in December in London.

Dr. David Waters is the recipient of the Center on Aging and the Life Course's (CALC) Outstanding Professor Award.Waters is professor emeritus in the College of Veterinary Medicine and a CALC faculty associate. Waters teaches biology of aging and received numerous student nominations for the award, which recognizesexceptional teaching and mentoring of emerging scholars in aging. He is director of the Center for Exceptional Longevity Studies at the Gerald P. Murphy Cancer Foundation.

* * * * *

Orr Fellowship, a postgraduate professional development program based in Indianapolis, has recently selected four Purdue seniors as Orr Fellows. The Orr Fellowship is one of Indianas most celebrated nonprofit talent programs. The students Miguel Diaz, Sean ODell, Eleanor Hamilton and Hannah Vanderbosch were chosen out of nearly 1,300 applicants and will begin at one of 46 Orr Fellowship partner companies upon graduating in May. They also will participate in Orr Fellowship programming dedicated to nurturing entrepreneurship and developing strong leadership skills.

Christine McCall, a graduate research and teaching assistant in the College of Health and Human Sciences, earned a top honor from the National Council on Family Relations for a paper. McCall won the Outstanding Student and New Professional Paper Award for her paper titled A Part of Our Family? Effects of Psychiatric Service Dogs on Quality of Life and Relationship Functioning in Military-Connected Couples.

Read more:
Appointments, honors and activities - Purdue News Service

Read More...

Hemp Feed Coalition submits the first ingredient application in the United States for hemp to be federally approved as a feed ingredient for poultry -…

February 7th, 2021 3:53 am

Hemp Feed Coalition announces the first submission for hemp to become an approved animal feed ingredient.

"The coalition has worked hard over the last two years and we are finally getting our first steps behind us in the world of federal approval; something that most every day Americans would be shocked to know is so heavily regulated. HFC doesn't just represent the hemp industry but all the farmers and ranchers out there that deserve the opportunity to monetize their efforts and compete on the global market of industrial hemp." - Morgan Elliott, Co-Founder of IND HEMP.

Now that the first application has been submitted, the HFC will turn its focus to research on other hemp by-products: oil, sediment, hulls, pulp and screenings to investigate their benefit and safety as feed ingredients. In addition, this work will include the clinical trials necessary to add ruminates to the hempseed meal application that was submitted. "Opening new markets is our secondary mission," said Buffington "Commoditizing safe and healthy by-products from hemp processing will provide farmer and processor revenue and a build a steady supply as the industry matures in the next few years." The HFC will be leading those efforts by bringing researchers, hemp and feed industry experts and coalition advisors together for additional applications and Federal regulatory approval for new hemp ingredients as feed for animals.

The Hemp Feed Coalition (HFC) began in 2018 as a pilot project under the Colorado Hemp Industries Association (COHIA) before forming its own non-profit organization in 2020. The HFC intends to continue its mission to gain federal approval for additional hemp by-products as commercial animal feed. To support the work of the HFC, visit our websiteand become a member. Members receive discounts, special offers, invitations and member only communications. For more information on current research and ingredient data collection contact Hunter Buffington at [emailprotected]

Press release supported by New West Genetics, Inc.

SOURCE Hemp Feed Coalition

Go here to see the original:
Hemp Feed Coalition submits the first ingredient application in the United States for hemp to be federally approved as a feed ingredient for poultry -...

Read More...

A Corpus Christi native survived a shark attack in the Caribbean. Here’s how you can help. – KIIITV.com

February 7th, 2021 3:53 am

Brook Toussaint had to have emergency surgery to have her leg amputated after the bite.

CORPUS CHRISTI, Texas Surviving a shark attack puts you in an elite class with an incredible tale to tell. One Corpus Christi native has one of those harrowing stories.

Brook Toussaint has always been an animal lover, her family said.

When she wasn't busy adoring animals, Brook spent her time in the water as a lifeguard and on a swim team.

Combine those two passions, and her sister Paige said it should not come as a surprise that Brook loved marine life.

"I can safely say she's an animal lover," Paige said. "Dolphins have always been her favorite animal, so she's always been attracted to the sea."

Brook was so attracted to sea life that she spent seven years as a volunteer for the Texas Sealife Center and is currently pursuing a degree in Veterinary Medicine at a university on an island in the Caribbean.

But it was one day back in January when Brook's life changed forever. Brook went for a swim with some friends off the coast of an island in the Caribbean when she felt something bit her leg.

"It turns out it was a tiger shark and my sister bravely fought it off," Paige said. "She literally punched it in its nose and gouged its eyes to get it to let go of her leg."

The quick thinking and bravery of Brook and others helped save her life. After having emergency surgery, she had to have her leg amputated.

The life-saving care has come at an enormous cost.

"And then the hospital stays and the rehab, it's adding up very quickly," Paige said.

Brook's family has set up a GoFundMe for the medical expenses. Their goal is $250,000, but with the support of the Coastal Bend community and beyond, they have already raised over $80,000.

For the latest updates on coronavirus in the Coastal Bend, click here.

More from 3News on KIIITV.com:

See the original post:
A Corpus Christi native survived a shark attack in the Caribbean. Here's how you can help. - KIIITV.com

Read More...

Model organisms are more than just monkeys and mice – DW (English)

February 7th, 2021 3:52 am

Model organisms or research organisms, as they are also known are living things that scientists, such as biologists, use to study human and other animal or plant life.

A model organism can be anything from single-celled bacteria to viruses and fungi. They can be more complex organisms, such as monkeys, mice, rats, frogs, elephants and a salamandercalled axolotl.

Monkeys and mice are considered incredibly important for the study of human disease and ageing, because they are genetically so similar to humans. And research on primates and rodents has led to some major scientific breakthroughs.

Illustration by Per Sander

The field is not without its opponents, though, and let's not mince our words its downsides.

One of the most basic scientific and ethical questions asks whether it's okay to subject non-human animals to experimental pain in a laboratory when we wouldn't do that with humans.

Think of vaccines and other medicines: Before they get tested on people, they are tested on non-human animals to look for dangerous side-effects.

Even further down the track, in human clinical trials, people can have extreme and adverse reactions to a drug in development. And that's when the drug has been somewhat refined to limit negative outcomes.

Illustration by Simone Hls

But with monkeys and rats, is it okay to just go ahead and test potentially lethal chemicals? Or what of psychological trials, like studying pain stimuli on mice? Is that okay? Does that mean that a monkey's life is worth less than a human life?

There are regulations to ensure the welfare of animals in research and, increasingly, some technical alternatives, such as computing models that use artificial intelligence and machine learning systems.

They can calculate what may happen if you put a medicinal compound in a body. But you can't avoid testing medicines on animals, including humans, in the end. How else would you know whether there are any benefits for human life?

Illustration by Simone Hls

There are less controversial model organisms than monkeys unexpected yet common things such as tomatoes, fruit flies, worms, and other vegetation. The axolotl is especially interesting because it keeps it's tadpole-like juvenile characteristics into adulthood. This includesexternalgills. But it is not a fish, it's a salamander.

One such plant is even celebrating the 200th anniversary of its naming, or to be precise, its renaming, and that's Arabidopsis thaliana.

A Swiss botanist called A.P. de Candolle coined the term Arabidopsis to describe a group of Brassicaceae plants in the mustard family in 1821.

In a paper published in the Journal of Plant Biochemistry and Biotechnology, Rajnish Khana and Ulrich Kutschera explain how a German botanist, Friedrich Laibach, then "established the mustard plant A. thaliana (L.) Heynh as a model organism in plant genetics []."

It has since become integral to stem cell research and is still delivering insights.

Illustration by Barbara Scheid

Khana and Kutschera write that A. thaliana is an ideal model organism for some very basic reasons: it's small and easy to grow, it has a short generation time the average time from the birth of one living thing to the birth of its offspring it produces up to 10,000 seeds per plant, and it's easy to manipulate and mutate.

Model organisms are categorized into various groups. The categories start with viruses, such as Phage lambda and the Tobacco mosaic virus.

Illustration by Christian Kuhn

The Lambda phage, for instance, is what's known as a temperate virus, which infects host bacteria, such as E.coli.

Being temperate, Phage lambda has different ways of infecting a cell, but it has to decide which it wants to use. And it's that decision-making process at such a fundamental level of life that has intrigued scientists. Studying the process allows them to learn about our own biological development.

Some researchers say it's important to continue studying viruses on the brink of global eradication, such as polio.

Even viruses such as Ebola, Zika and influenza can be used as model organisms to teach us about genetic and hereditary processes in RNA, the messengers of DNA the thing that makes living things unique individuals.

The next category is Prokaryotes. A prokaryote is any organism that lacks a distinct nucleus, the thing that controls the activity of a cell.

Illustration by Barbara Scheid

The most common prokaryotes are bacteria, such as E.coli (Escherichia coli), which is used to study molecular genetics. Synechocystis is a bacterium that is commonly used to research photosynthesis.

Next on the list and arguably the largest and best-known group involves eukaryotes. Eukaryotes are cells or organisms that are thought to have evolved about 2 billion years ago.

Compared to prokaryotes, eukaryotes have a clearly defined nucleus.

They include protists. Protists are often but not exclusively microscopic, single-celled organisms.

Illustration by Christian Kuhn

Eukaryotes also include fungi. There's Neurospora crassa, an orange bread mold, for instance, that's been used to study metabolic regulation and the circadian rhythm the latter being a field that won a Nobel Prize only a few years ago.

Baker's yeast is used in genetic research, as are Coprinus cinereus mushrooms. They have been useful in the study of meiosis, or cell-division, which is important for understanding reproduction.

Arabidopsis thaliana, mentioned above, is also a eukaryote. It belongs to a group of so-called higher plants.

Illustration by Peter Steinmetz

Then there are animals, both invertebrate and vertebrate.

Let's start with invertebrate animals. The US National Wildlife Federation describes invertebrates as the "most diverse and numerous group of animals on Earth."

Invertebrates have no spine. They can live on land or in water.

Illustration by Simone Hls

So, they include animals such as the common fruit fly and hydra, an aquatic animal.

Many have been used in molecular biology or biomedical experiments.

And last, but by no means least, we have the vertebrates arguably, the most controversial group of model organisms.

Vertebrates are defined by their having a spine.

Illustration by Olof Pock

Now, if you wanted to be cynical, you may like to suggest that some vertebrates have more of a spine than others. We humans, for instance, could be accused of being spineless for willingly subjecting other animals to pain that we would rather not endure ourselves. But that argument is up for grabs.

The usual suspects among the vertebrate model organisms are the aforementioned monkeys, rats and mice. But they also include dogs, frogs, chickens and cats, and birds used to study communication among songbirds and non-mammalian auditory systems.

Then there's the beautiful zebrafish, a freshwater tropical specimen.

Zebrafish are virtually transparent. That offers scientists with an almost unique view of an animal's internal anatomy.

Illustration by Simone Hls

But if that's not cool enough, Zebrafish are becoming more and more attractive as a model organism because about 70% of their genes are similar to human genes.

They also have similar bodily components or organs. Zebrafish have two eyes, a mouth, a brain, intestine, pancreas, liver, bile ducts, kidney, a heart, ears, nose, cartilage, and teeth just like humans.

Researchers says it's therefore possible to use zebrafish to model and study genetic changes, which in humans would lead to disease.

That's also one reason why some researchers say zebrafish are becoming more popular in the lab than mice.

Illustration by Simone Hls

Mice are not to be discounted, however. German scientists recently reported that they had cured mice of paralysis after the animals had suffered a spinal cord injury.

But the use of animals, especially those so genetically close to humans, with all the scientific benefits for human life, remains contentious for both scientists and observers of research that uses mammalian model organisms.

Germany's Max-Planck Society writes that "monkeys are used in animal research only if a particular phenomenon cannot be studied on any other species of animal, such as mice, fish or fruit flies. [] They are used primarily for the final drug safety tests on new medicines before they are used on humans."

That is one perspective. Elsewhere, scientists are moving from mice to monkeys.

Illustration by Benjamin St

A feature article in Nature has suggested that cynomolgus macaque monkeys (also known as long-tailed or crab-eating macaques) may be the focus of a "new era of animal models for autism and other brain and psychiatric diseases."

Macaques are already among the most commonly used non-human primates in biomedical research.

The RSPCA, an animal welfare charity in the UK, saysprimates are "highly intelligent animals [] that suffer in similar ways to us."

It goes on to say that "the capture of wild primates for use in breeding colonies and for experiments in some countries causes very significant suffering we believe this is completely unacceptable."I

llustrations by Simone Hls, Christian Kuhn, Olof Pock, Per Sander, Barbara Scheid, Peter Steinmetz, Benjamin St

At a depth of 3,700 meters (12,000 feet), dozens of natural chimneys stick up from the seafloor emitting hot fluid at 290 degrees Celsius (554 degrees Fahrenheit). Over thousands of years, towers of lime have piled up. This is the hydrothermal vent field of the Pescadero Basin, about 150 kilometers east of La Paz in Mexico in the Gulf of California. A marvelous place!

US researchers at the Monterey Bay Aquarium Research Institute discovered the deep-sea vent field at Pescadero Basin in 2015. A few months ago, a research team went back on board the Schmidt Ocean Institute ship Falkor to explore this special place. They mapped the seafloor, recorded high-resolution video and brought back rocks and animal samples.

Due to volcanic activity underground, hot water creeps out of the seafloor, containing chemicals such as hydrogen sulfide - a gas that smells like rotten eggs. It is extremely toxic to humans, but some bacteria can metabolize it and gain energy from it. Those bacteria thrive down here at Pescadero Basin and form these thick, fluffy looking bacterial mats.

The vents are buried in the sediment, so the hot liquid reacts with rocks before it escapes. Therefore, the liquid is clear (like you can see in this picture). At another type of vent called a 'black smoker', dark, metal-rich fluid leaves the chimneys instead. Pescadero harbors life quite different from that what was found at other vent fields explored previously.

The vents are densely covered with tubeworms (Oasisia alvinae). These sessile invertebrates live in chitin tubes just a bit wider than their body. Tubeworms like this one were discovered in the 1970s at a vent field near the Galapagos. The researchers were amazed by how many of these animals live at Pescadero. They are literally everywhere.

Oasisia tubeworms dont have a mouth or a digestive system. Instead, the animals take up hydrogen sulfide and oxygen from the water with their orange-red plumes. They feed the nutrients into a bag filled with bacteria. The bacteria then generate energy for them. It works similar to the bacteria in our guts digesting food for us.

In Pescadero Basin, researchers found species they hadnt seen anywhere else before. Like this iridescent blue scale worm, named Peinaleopolynoe orphanae. Across their back, they have thick discs that refract light - just like the wings of a butterfly. The researchers watched the creatures fighting with each other. They have big jaws which they can project during a fight.

This strange creature is called Xenoturbella profunda, but scientists often call it simply the sock worm. This turns out to be quite literal they are just a bag with a mouth underneath. Scientists saw these strange animals gliding very slowly over the seafloor. They seem to feed on clams, as researchers found clam DNA inside their bodies. How they catch and eat their prey? Nobody knows.

Some animals such as tubeworms, scale worms and Xenoturbella live directly on the hydrothermal vents. Others, though, just float by, like fish or octopuses. Or this guy here, a siphonophore. It resembles a jellyfish, but it's not one. Its more closely related to the venomous Portuguese man o' war.

Apart from animals and rocks, there is more to see in the Pescadero Basin. Underwater lakes like this one, for example. They develop when hot fluid gets trapped under rocks or within caves and cannot escape.

An underwater-robot pilot on the ship steers the remotely-operated vehicle from vent to vent. Via a tether, the robot sends back data and high-resolution video footage to the surface. The researchers can thus see in real-time whats going on down there. An awesome experience, for sure.

The underwater robot has an arm with which it can pick up rocks and animals and bring them back to the surface. But most animals lose their colors and shape pretty soon when conserved in alcohol in the researchers lab. This for a example is a sea cucumber from Pescadero Basin, beautifully colored in life not anymore.

Author: Brigitte Osterath

Original post:
Model organisms are more than just monkeys and mice - DW (English)

Read More...

PLUs Lathiena Nervo discusses her work and being named one of the 1,000 inspiring Black scientists in America – Pacific Lutheran University

February 7th, 2021 3:52 am

College was always important to my parents. Neither of them went to college and it was always clear growing up that the expectation was that we were going to go to college. But during high school, I didnt have any idea what I was going to go to college for and what my passion was for, until that AP Biology class.

What made you decide on research and teaching, as opposed to medical school or the many other careers a biology student can pursue?Its a roundabout story, but essentially I thought I wanted to go to medical school. I wanted to be a pediatrician, and that was to be my focus. But then I had a research experience as an undergraduate that really opened my eyes to what experimentation is, how to think about big questions, and how to figure out what experiments will help get you closer to the answers to those questions.

Then, after finishing my undergrad, I started teaching high school biology and I realized how much I loved to teach. I taught at a Catholic school with a very small minority population. I didnt realize going into it how much my presence would mean to those students.

How did teaching in that high school shape how you teach now?Well, soon after I started there I had a lot of the underrepresented minority students in my classroom after school and during lunch. Just wanting to talk about their experiences in life. For many of them, I was their first Black teacher that theyve ever had, and I taught 10th graders. That experience really opened my eyes to what Ias a Black woman in science and as an educatorrepresent. That was the moment where I started thinking that I really love science and I wanted to do experimentation, but I also wanted to focus on mentorship. I wanted to be a mentor, I wanted to increase underrepresented minority participation in science, and get those students loving science. And that was the spark that started that. I then worked for a couple of years for a NASA-funded program, where that was actually their focusto increase the underrepresented groups participation in science.

I realized that I wanted to teach and conduct research at a primarily undergraduate institution. So I went into grad school with that goal in mind. I was a non-traditional student, going back several years after completing my bachelors degree. I received grants through my graduate school department and the US Department of Education. I participated in a postdoctoral fellowship thats specific for teaching scientists to be better educators. When I finished my PhD, I went into that fellowship program. And now Im excited to be here at PLU, focussed on these three core elements of teaching, increasing representation in my field, and conducting research.

Continue reading here:
PLUs Lathiena Nervo discusses her work and being named one of the 1,000 inspiring Black scientists in America - Pacific Lutheran University

Read More...

Dascena Strengthens Executive Leadership Team with Key Appointments and Promotion – Business Wire

February 7th, 2021 3:52 am

HOUSTON--(BUSINESS WIRE)--Dascena, Inc., a machine learning diagnostic algorithm company that is targeting early disease intervention to improve patient care outcomes, today announced it is expanding its leadership team with the C-suite appointments of Jim Wingrove, Ph.D., as Chief Scientific Officer and David H. Ledbetter, Ph.D., as Chief Clinical Officer. Jonathan Roberts has been awarded the title of Chief Growth Officer.

We are thrilled to welcome Jim and David to the Dascena executive leadership team. In addition, Jonathan has earned this promotion through his leadership and significant contributions in helping advance Dascena to where we are today. As we build out our predictive algorithm roadmap, they each will play an integral role in our future success, said Ritankar Das, Chief Executive Officer of Dascena. Jims expertise in research and lab leadership will position Dascena for significant growth and execution in diagnostics and overall scientific strategy. Davids disciplined clinical strategy and research experience will be essential as we continue to explore the application of our algorithms and the impact they may have on healthcare systems and patients around the globe.

Jim is responsible for the management of Dascenas R&D and CLIA labs, as well as for guiding overall scientific strategy. Jim brings over 25 years of experience in molecular genetics and genomics. Prior to Dascena, Jim was Vice President of R&D at DotLab, where he established the company's R&D and CLIA labs. Prior to DotLab, Jim was Vice President of technical operations at CardioDx, where he was a co-inventor of the company's lead diagnostic product and led multiple groups, including R&D and the company's CLIA/CAP/NYS lab. Jim was a Life Science Research Foundation Fellow in the biochemistry and biophysics department at UCSF and completed his doctoral research in biochemistry at UCLA. He is an author of numerous scientific publications, including articles in Cell, Science and Nature.

David is a clinical strategy leader at Dascena focusing on new products, health systems partnerships and research. David joins Dascena from Geisinger where he was the founding Chief Scientific Officer and Executive Vice President and built one of the largest genomics and precision health programs in the world. Prior to Geisinger, David was a professor of human genetics at Emory University School of Medicine. Earlier in his career, he was a professor and founding chair in the department of human genetics at the University of Chicagos School of Medicine and Branch Chief, Diagnostic Development Branch at the National Human Genome Research Institute. David is board-certified by the American Board of Medical Genetics and Genomics as a clinical laboratory geneticist and is a highly accomplished researcher, authoring over 300 peer-reviewed publications. He completed his undergraduate work at Tulane University and his Ph.D., in psychology (behavioral genetics) at The University of Texas at Austin.

About Dascena

Dascena is developing machine learning algorithms to enable early disease intervention and improve care outcomes for patients. For more information, visit dascena.com. Follow us on LinkedIn.

View post:
Dascena Strengthens Executive Leadership Team with Key Appointments and Promotion - Business Wire

Read More...

Bioinformatics Services Market | Know the Latest Innovations and Future Market Scope – BioSpace

February 7th, 2021 3:52 am

Bioinformatics is the field mainly involving molecular biology, genetics, mathematics, statistics, and computer science. The bioinformatics services include analysis of the data that can range from processing sequencing reads from instrument to data aggregation and mining data samples. Bioinformatics services can help biologists to understand the biological process with a computational intensive technique for machine learning algorithms, pattern recognition, data mining and visualization.

Bioinformatics tools can help to compare genomic and genetic data and understand evolutionary aspects of molecular biology. Bioinformatics services are finding wide application in chemoinformatics, genomics, metabolomics, RNA-seq analysis, and drug design. The database is an important part for bioinformatics research and application to cover various information types including molecular structure, protein and DNA sequences, and phenotypes in bioinformatics services.

Get Brochure of the Report @ https://www.tmrresearch.com/sample/sample?flag=B&rep_id=4836

Bioinformatics Services Market: Notable Highlights

Buy this Premium Report @ https://www.tmrresearch.com/checkout?rep_id=4836&ltype=S

Some of the most prominent competitors operating in the competitive landscape of global bioinformatics services market include

Bioinformatics Services Market Dynamics

Bioinformatics Services Finding Wide Application in Personalized Medicine Discovery

With the increasing prevalence of various diseases, new treatments and drugs are being discovered and developed. Extensive molecular biological data on patients is being included on a large scale in diagnosis and treatment. Bioinformatics services is fundamental to precision medicine as developing personalized medicine depends on accessing genetic and molecular data. In recent years, the majority of the molecularly targeted drugs have been developed based on the detected gene mutation.

Next-gen sequencing in bioinformatics services is emerging as an important tool in genomic analysis and developing personalized medicine. Next-gen sequencing along with microarrays in bioinformatics services have also paved the way for precision medicine in oncology. Meanwhile, increasing availability and decreasing the cost of next-gen sequencing is allowing worldwide cancer centers to offer next-gen sequencing based personalized oncology for clinical practice while suggesting specific medicine and treatment.

Increasing Initiatives by Governments and Private Organizations in Bioinformatics Services

With increasing application of new technologies in life science, governments and organizations across various countries are investing in the new technologies and in research and development activities in bioinformatics services. According to the Global Alliance for Genomics and Health (GA4GH), around 60 million genomes are likely to be sequenced by 2025. Moreover, with the presence of national clinical genomic initiatives worldwide, the generation of genomic data in healthcare is expected to outpace that in research in the coming years. Governments across countries are increasingly investing in the biotechnology and bioinformatics services to effectively implement new technologies and support genomic and epidemiological research.

Countries such as the US, UK, Australia, France, Japan, Saudi Arabia, Qatar, Denmark are developing new strategies for projects focusing on cancer and rare diseases, along with the use of sequencing services and genomic data. New research activities are also being conducted for application of bioinformatics services in biodefense. The Mid-Atlantic Microbiome Meet-up (M3) is focusing on the use of next-generation sequencing technologies and recent advances in biodefense, especially related to infectious diseases, and also using metagenomic methods for detection.

Shortage of Skilled Workforce and High Cost Hampering the Bioinformatics Services Market Growth

Although bioinformatics services is emerging as an important part of research in life science, lack of skills and knowledge in bioinformatics is hindering its growth. With the technological and process advancements in biotechnology, it has become imperative that bioinformatics techniques are performed by skilled personnel. However, the need for heavy investment in tool upgradation and installation training is impeding the growth of bioinformatics services. Owing to this there is a lack of skilled manpower in bioinformatics services who can adapt to the high-end bioinformatics techniques and processes.

Moreover, the lack of skilled professionals in bioinformatics services is also hampering the growth of clinical laboratories as they are focusing to automate processes. However, in recent years, governments along with healthcare institutions are focusing on strategies to provide new courses in bioinformatics as it holds a big promise in solving many health related and environmental issues.

Get Table of Content of the Report @ https://www.tmrresearch.com/sample/sample?flag=T&rep_id=4836

Bioinformatics Services Market Segmentation

Based on the type, the bioinformatics services market is segmented into

On the basis of application, the bioinformatics services market segment includes

Based on the specialty, the bioinformatics services market is segmented into

Based on the end-user, the bioinformatics services market segment includes

About TMR Research

TMR Research is a premier provider of customized market research and consulting services to business entities keen on succeeding in todays supercharged economic climate. Armed with an experienced, dedicated, and dynamic team of analysts, we are redefining the way our clients conduct business by providing them with authoritative and trusted research studies in tune with the latest methodologies and market trends.

Contact:

Rohit Bhisey

TMR Research,

3739 Balboa St # 1097,

San Francisco, CA 94121

United States

Tel: +1-415-520-1050

Visit Site: https://www.tmrresearch.com/

See the article here:
Bioinformatics Services Market | Know the Latest Innovations and Future Market Scope - BioSpace

Read More...

Risk Factor For Bacterial And Viral Co-Infection Uncovered – Forbes

February 7th, 2021 3:52 am

Tiny bubble-like sacs called vesicles that travel around and between cells in the body can help to initiate and worsen secondary bacterial infections in people already infected with viral lung infections like colds, flu or even Covid-19.

According to research from the University of Pittsburgh School of Medicine, viral infection triggers the release of these iron-loaded vesicles, which then feed the bacteria with iron and encourage them to form hard-to-treat biofilms.

There is still a lot we need to learn about how microbes exploit the host during infections, especially in the complex setting of polymicrobial interactions, says the lead researcher on the study Jennifer Bomberger, an associate professor in the Department of Microbiology & Molecular Genetics at the University of Pittsburgh.

Understanding factors that permit the establishment of chronic infections, like those that are so devastating to patients with chronic lung diseases, is my laboratorys goal.

It is a known problem that a significant proportion of people who become infected with viral lung infections go on to develop secondary bacterial infections like pneumonia. This can be particularly problematic in patients with chronic lung conditions such as cystic fibrosis. However, less is known about factors that increase a persons risk for these secondary infections.

Bacterial pneumonia

For example, in the current pandemic more than a quarter of patients admitted to the emergency room with serious Covid-19 have also developed secondary bacterial infections. But what spares the other 60-75% of patients from these secondary infections is less clear.

The development of chronic bacterial infections often is preceded by acute viral infections, and such co-infections increase patients likelihood of death or lifelong disability, comments Bomberger. We wanted to understand what it is that the virus is doing that allows bacteria to get a foothold in the patients airways.

Vesicles are very common in the space between cells and often act like a delivery service taking proteins, genetic material like RNA, or fats, from one place in the body to another. Although they have been reported to change the local environment during viral infections and regulate virus-host interactions, very little is understood about the role they have in mediating between bacteria and viruses.

The bacteria Pseudomonas aeruginosa is known to cause a number of bacterial infections such as pneumonia and sepsis and can be difficult to treat due to drug resistance and biofilm formation. Bomberger and colleagues assessed links between infection with respiratory syncytial virus, which causes one type of common cold, and subsequent infection with P. aeruginosa in people with cystic fibrosis.

Weve previously shown that acute viral infections can change the environment of the respiratory tract to allow bacteria to grow as biofilms, communities of bacteria that are highly antibiotic resistant, says Bomberger.

Using various imaging and laboratory techniques the team found that vesicles released from lung tissue infected with respiratory syncytial virus seem to help P. aeruginosa bacteria form biofilms by feeding them iron.

Cells secreting exosomes, one type of extracellular vesicle found in the body.

It was not previously known that bacteria would interact with these vesicles made by the human host, so this now informs our thinking about many infection situations, but also leads us to think about new therapies based on the nutrients delivered on these host vesicles, says Bomberger.

Whether the amount of iron a person has in their blood, or other factors, influence the degree to which viral iron-charged vesicles are produced is unclear. But it is certainly true that iron is an important nutrient for many bacteria.

A possible treatment strategy like removal of excess iron via chelation drugs could be one new approach, probably used in combination with standard antimicrobials to treat the bacterial infections, according to Bomberger.

The research team now wants to investigate the relationship between the bacteria and these vesicles further. They also want to confirm their findings in patients with different types of co-infections and assess what impact these vesicles have on the patients immune system.

It would be interesting to see the implications this mechanism has for the hosts immune response, says Matthew Hendricks, a researcher at the University of Washington School of Medicine, who worked on the study while a graduate student in Bombergers laboratory.

If extracellular vesicles can shield bacteria from the immune cells, that could decrease the hosts ability to detect the infection and help bacteria evade the immune response.

Follow this link:
Risk Factor For Bacterial And Viral Co-Infection Uncovered - Forbes

Read More...

Plants May Be Able To Control the Genetics of Their Microbial Symbionts – Technology Networks

February 7th, 2021 3:52 am

Researchers from the University of Ottawa have discovered that plants may be able to control the genetics of their intimate root symbionts - the organism with which they live in symbiosis - thereby providing a better understanding of their growth.

In addition to having a significant impact on all terrestrial ecosystems, their discovery may lead to improved eco-friendly agricultural applications.

We talked to research lead Nicolas Corradi, Associate Professor in the Department of Biology and Research Chair in Microbial Genomics at the University of Ottawa, and lead author Vasilis Kokkoris, Postdoctoral Fellow in theCorradi Lab, to learn more about their recent study published in the journalCurrent Biology.

AMF are plant obligate symbionts that grow within the plant roots and help their hosts to grow better and be more resistant to environmental stressors.

AMF genetics have long been mysterious; while typical cells carry one nucleus, the cells of AMF carry thousands of nuclei that can be genetically diverse. How these nuclei communicate with each other and whether the plants can control their relative abundance, has been a total mystery.

Our work provides insights into this unique genetic condition:

1- We demonstrate that the host plant symbiont influences the relative abundance of thousands of co-existing nuclei carried by their fungal symbionts.

2- We find evidence that co-existing nuclei of different genetic backgrounds cooperate, rather than compete with one another thus potentially maximizing growth benefits for both the fungi and their plant partners."

By analyzing single spores, we were able to quantify the genetics of thousands of nuclei and define their relative abundance in different fungal strains and across plant species.

To ensure that we accurately analyze single nuclei, we used advanced microscopy to visualize and count the nuclei in the spores.

Lastly, we used mathematical modelling to prove that the observed abundance of nuclear genotypes we identified cannot be a product of luck but instead is the result of a driven cooperation between them.

To better understand what is regulating the AMF nuclei we grew different AMF strains with different hosts and found that plants have control of the relative abundance of the fungal nuclei."

Our research provides an answer as we demonstrate that the genetics of these fungi, and their effect on plant growth, can be manipulated by plants thus explaining the reason for the observed variability on plant growth.

From an environmental standpoint, this new knowledge allows for better understanding how plants can influence the genetics of their symbiotic partners, thus influencing entire terrestrial ecosystems.

From an economic standpoint, it opens doors to improved sustainable agricultural applications."

Reference: Kokkoris V, Chagnon P-L, Yildirir G, et al. Host identity influences nuclear dynamics in arbuscular mycorrhizal fungi. Current Biology. 2021. doi:10.1016/j.cub.2021.01.035.

This article has been republished from the following materials. Note: material may have been edited for length and content. For further information, please contact the cited source.

Read more:
Plants May Be Able To Control the Genetics of Their Microbial Symbionts - Technology Networks

Read More...

The mistrusted medical miracle: Vaccines have revolutionized health, but some still question their safety – Charleston Gazette-Mail

February 7th, 2021 3:52 am

In 1775, Gen. George Washington was fighting two enemies. His visible enemy was the British, with whom the Colonists had begun fighting at the battles of Lexington and Concord. Washingtons second enemy was invisible, but deadlier than British muskets: smallpox.

A smallpox epidemic threatened Washingtons Continental Army. Fortunately, Washington had experience with the disease (he had caught and survived smallpox while in the Caribbean Islands) and sought to have his troops inoculated.

Inoculation was new and controversial in Colonial America, even outlawed in places. It didnt help that the method of inoculation practiced at the time was risky. Called variolation, the procedure entailed making a small incision in a patients arm and inserting a dose of the live virus large enough to trigger immunity but small enough to prevent severe illness or death, writes Andrew Lawler in an April 2020 National Geographic article.

But Washington was a firm believer in the science-based treatment. While soldiers already in the army were given a choice (and many refused), Washington insisted that all new recruits be inoculated. By the end of 1777, some 40,000 soldiers had been vaccinated.

A compelling case can be made that his (Washingtons) swift response to the smallpox epidemic and to a policy of inoculation was the most important strategic decision of his military career, Lawler quotes historian Joseph Ellis as saying.

This story touches on the dilemma of immunization as a medical treatment. On the one hand, vaccines have saved millions of lives. Yet despite being applauded as a medical miracle, vaccines have always generated a level of public distrust.

This is not a new problem. It has waxed and waned ever since weve had vaccines, said Dr. Christopher Martin, a professor in the West Virginia University Schools of Public Health and Medicine. Martin also serves on the West Virginia COVID-19 Vaccine Medical Advisory Group.

When it comes to vaccine hesitancy, people fall along the spectrum. At one end are people like me, who love vaccines. Whenever a new vaccine comes up thats indicated for me, I get it right away, Martin said.

Theres another group at the other end of the spectrum that are completely resistant to any kind of data or argument. Theres nothing you can say. As my Irish father used to put it, you might as well save your breath to cool your porridge.

But most people fall somewhere in the middle. These are the ones Martin tries to reach. Calling someone anti-science isnt helpful, he said. We have to tailor the message. In focus groups it came out that West Virginians concern is I dont want to be told to have this vaccine. They are concerned about personal liberties.

Thats why our theme for the COVID vaccine is that its a choice. We try to get people to understand what a powerful decision they can make to protect themselves.

A brief look at how vaccines developed in this country can shed light on the present cultural divide.

While variolation can be traced back to ancient China, it is Edward Jenner who is generally credited with devising the first vaccine. In 1796, he inoculated a 13-year-old boy with the vaccinia virus (cowpox) and demonstrated that it gave immunity to smallpox. The practice quickly became widespread.

Louis Pasteur began experimenting with attenuated vaccines in the late 1800s. Attenuation takes an infectious pathogen (a bacteria or virus) and makes it less virulent. Although weakened, the pathogen is still viable.

Pasteur developed a rabies vaccine in 1885. His research led to other attenuated vaccines, including ones for cholera, anthrax, measles, mumps, rubella and yellow fever.

Attenuated vaccines are in contrast to inactivated vaccines where a killed, nonviable version of the germ is used. Generally, inactivated vaccines do not provide long-term immunity; additional shots could be necessary (the annual flu shot is an example).

Over the next 200 years, mass implementation of the smallpox vaccine led to the disease being eradicated globally in 1979 one of the greatest successes of modern medicine.

Research for a polio vaccine began in the 1930s. Jonas Salk was the first virologist to become a celebrity after he developed an inactivated polio vaccine in 1954.

Polio is a disabling disease caused by the poliovirus. It can infect a persons spinal cord, causing paralysis and sometimes death.

Children are especially vulnerable, and 1950s American families were terrified of the disease. It was said fear of polio was second only to fear of the atom bomb. An epidemic in 1952 resulted in more than 21,000 paralytic cases and more than 3,000 deaths, according to the Centers for Disease Control.

In 1955, a nationwide polio inoculation campaign began for schoolchildren, sponsored by the March of Dimes. But the campaign was quickly suspended when it was discovered that Cutter Laboratories in California had produced defective batches of the vaccine.

Cutter was one of five companies producing the polio vaccine. A flaw in the labs manufacturing process led to batches of vaccine being distributed where the virus was not inactivated. As a result, more than 200,000 children received a polio vaccine that contained live, viable virus. It was later determined that the faulty batches caused an estimated 40,000 cases of polio, with about 200 cases leading to paralysis. Ten children died.

As tragic as these numbers were, they were a small fraction of the casualties caused by natural polio each year during this period.

The incident led to tighter federal regulations overseeing the production of vaccines. Pharmaceutical companies made improvements to their production processes and applied more rigorous safety testing. The inoculation campaign was resumed and polio cases began to drop.

The Salk vaccine was later replaced by an oral attenuated vaccine. Many of the Baby Boom generation remember lining up as schoolchildren in the 1960s to swallow a sugar cube dosed with the polio vaccine.

By 1979, there were no new cases of polio originating in the United States. The World Health Organization and other groups are still working to eradicate polio globally.

Not surprisingly, Cutter Laboratories was taken to court over its botched rollout of the vaccine. In the landmark case they were declared not at fault, but still liable for their product. This liability without negligence decision would have major repercussions for the pharmaceutical industry.

Dr. Paul A. Offit addressed the mixed legacy of this legal precedent in his 2005 book, The Cutter Incident: How Americas First Polio Vaccine Led to the Growing Vaccine Crisis. He contends that the verdict in the court case against Cutter made vaccine manufacturers an easy target for litigation and huge monetary awards from juries.

Such litigation persisted despite overwhelming consensus from the scientific and health communities that vaccines were low risk and that adverse effects were rare. Pharmaceutical companies began to shy away from vaccine research and manufacturing because of liability issues.

Pharmaceutical and biotech companies continued to be hauled into court throughout the 1970s and 1980s, and supplies were threatened. By 1985, for example, only one company was still making the pertussis vaccine (for whooping cough) a critical vaccine for childhood safety.

Vaccines were the first medical product almost completely eliminated by litigation, Offit said, discussing his book in an American Enterprise Institute video in 2006.

Congress saw that action was needed to protect vaccine manufacturers and health care providers and passed the National Childhood Vaccine Injury Act in 1986, which included the National Vaccine Injury Compensation Program.

This law created a special vaccine court to handle disputes and shield vaccine manufacturers from most lawsuits. The law was upheld in a Supreme Court ruling in 2011.

Despite this protection, vaccine shortages became an intermittent problem. Offit gives more examples. In 1998, the tetanus vaccine was in such short supply that its use was restricted to emergency rooms. The flu season of 2003-2004 began early and created a demand that exceeded supply. The following year proved even worse with 30 million fewer doses of flu vaccine than the year before.

There have been shortages of nine of the 12 vaccines routinely given to children including the vaccine for meningitis (pneumococcus).

Parents could only hope that their children werent among the thousands permanently harmed or killed by pneumococcus every year, Offit writes.

Lyme disease is a bacterial infection transmitted to humans through the bites of certain types of ticks. Symptoms include fever, fatigue, joint pain and rash. Left untreated, the disease can lead to serious joint and neurological complications. The CDC says cases are on the rise. EPA studies show that climate change is likely a factor in increasing the range of ticks that carry infection.

Only one company has ever marketed a Lyme disease vaccine. SmithKline Beecham (now GlaxoSmithKline) licensed the LYMErix vaccine in 1998, and would end up distributing some 1.5 million doses.

Anecdotal reports surfaced of people who said they developed arthritis after getting the vaccine. Lyme disease itself can cause chronic arthritis, but controlled case studies did not show a higher incidence of arthritis as an adverse effect of the vaccine.

An advisory panel by the Food and Drug Administration confirmed this conclusion, as did a report from the National Institute of Allergy and Infectious Diseases, which concluded that the rate [of arthritis] was not shown to be elevated among vaccine recipients.

According to CDC statistics, some 23% of adults in the U.S. get some form of arthritis (in West Virginia, the figure is 33.6%). In all likelihood, the people who developed arthritis would have done so regardless of whether they received the vaccine or not.

Even though no credible evidence surfaced to link the vaccine to these claims, that didnt stop anti-Lyme vaccine groups from forming or media outlets from carrying their anti-vax message to the general public. A class action lawsuit was filed on behalf of 121 people.

It was a fiasco that has really never occurred to any other vaccine, said Dr. Stanley Plotkin, an emeritus professor of pediatrics at the University of Pennsylvania and veteran vaccine researcher, in a 2019 Scientific American article.

With demand dampened by the distrust and backlash, the company pulled the LYMErix vaccine from the market in 2002. Today, 20 years later, there still is no available human vaccine for Lyme disease.

While Lyme disease is not deadly, the same cant be said of COVID-19. But a significant segment of the population is showing hesitancy over receiving either of the two COVID-19 vaccines currently being distributed.

Advances in immunology, microbiology and molecular genetics have led to new categories of vaccines in recent years. Both the Pfizer/BioNTech and Moderna COVID-19 vaccines approved by the FDA for emergency use are made from messenger RNA (mRNA).

These vaccines are different from traditional vaccines discussed above, in that they do not contain either weakened attenuated virus or inactivated virus proteins.

Instead, mRNA uses synthetic genetic material that encodes a harmless piece of viral protein in this case, the spike protein in the SARS-CoV-2 coronavirus.

The synthetic mRNA issues this code to the bodys cells and teaches them to build the protein, which triggers the bodys immune response, the same as with a natural infection. This builds up our immunity to the virus. How long this immunity will last is still unknown.

The Pfizer and Moderna vaccines are the first mRNA vaccines to advance through all the clinical trial stages and be approved for use.

These vaccines use a new platform [mRNA], but theres no additional risk, Martin said. Long before COVID came out, we had done the science. All the pioneering work has been done.

In fact, research into mRNA vaccines has been ongoing for decades. If there was a real problem with the technology, wed have seen it before now for sure, said Michael Goldman, a professor of immunology and director of the Innovative Medicines Initiative, in Horizon, a European Union research and innovation publication.

Some people have expressed concerns, not with the mRNA platform as such, but with the compressed time frame in which COVID-19 vaccines were rushed into production.

But one of the advantages of the mRNA platform is speed. It takes far less time to produce a synthetic mRNA vaccine than with traditional vaccines.

Also, as Martin points out, in this case the companies began manufacturing the vaccines before clinical trials were completed. They did steps in parallel, which was a financial risk, not a safety risk, Martin said.

There is nothing different about the clinical studies that were done. Ive had both doses. The only negative experience for me is knowing its not yet available for more people.

Martin adds that psychological considerations come into play surrounding vaccine hesitancy. Nothing is risk free, he said. But we arent very good at perceiving risk accurately. Subjectively, doing nothing feels safer. People feel that doing something making a choice to get the vaccine is more risky. But it is clear that if you dont get vaccinated, you are at greater risk.

After releasing its instructions to the cells, the mRNA is quickly broken down by enzymes and does not enter the nucleus of a cell. Its not DNA. It has nothing to do with your genetic material, Martin said. And its not possible to get COVID from the vaccine.

Allergic reactions are possible, but very, very rare. If it happens, a reaction is entirely manageable. Vaccination clinics are easily equipped to handle that.

Some people have reported mild symptoms, particularly after the second shot. In a statement, the FDA said that the most commonly reported side effects, which typically lasted several days, were pain at the injection site, tiredness, headache, muscle pain, chills, joint pain, and fever ... more people experienced these side effects after the second dose than after the first dose.

But Martin takes issue with calling these side effects. You might feel unwell or have a low-grade fever, he said. Thats not a side effect thats the primary effect. Thats just your immune system at work. It means you are going to be one of the 95% who are protected.

Scientists question whether COVID-19 will ever be eradicated, as with smallpox, or even largely eliminated, as with polio. What is certain is that, whatever happens, vaccines and the publics willingness to trust them will play a major role.

Ultimately, overcoming a pandemic isnt just about science. Its about culture and the perceptions that people bring to science.

Excerpt from:
The mistrusted medical miracle: Vaccines have revolutionized health, but some still question their safety - Charleston Gazette-Mail

Read More...

Of a Feather: When cousins are two of a kind – eagletimes.com

February 7th, 2021 3:52 am

I have not yet seen any redpolls at my feeder this year, but it is only early February, so a birdwatcher can hope. When they do arrive, I dont plan to stress out about which species and subspecies are present. Because, frankly, it is difficult to tell them apart, and they are all adorable.

Poll is a Middle English word that means head. It is still occasionally used in that sense if you are talking about livestock. Polled cattle are the unhorned members of a breed, which is to say, they are just headed. Of course, we most commonly use the word to mean either a place to vote (going to the polls) or a collection of votes (taking a poll). This probably derives from the fact that people have only one head, but they have two hands. So, in a crowd it is safer to count heads to get an accurate count, as there are always jokers who will raise both hands.

Both the male and female redpolls have a prominent scarlet square right on top of their heads, while only the males have the blush of pink or red on their chests and sides. Hence, this is a cleverer name than, say, the rose-breasted grosbeak, which leaves out the female entirely.

Most sources recognize two species of redpoll, usually referred to in this country as the common and the hoary redpolls. In Europe, the hoary is called the Arctic redpoll. Both adjectives are accurate, more or less. We use the word hoary infrequently. Generally, we intend it to mean having a frosted appearance. Hoar frost is the kind of frost that grows in obvious crystals, like icy fur on objects. Hoar is an Old English word that means appearing to be old. Several animals and plants with a frosted appearance get this tag: the hoary bat, the hoary marmot, and hoary verbena.

Hoary redpolls have a more limited breeding range than do common redpolls. The Europeans might do better to call them tundra redpolls because they only live in that habitat. In contrast, the common redpoll breeds in the tundra, but it also nests down into the northern taiga of Canada. Hoary redpolls, for example, breed only around Ungava Bay in northernmost Quebec, but common redpolls build nests halfway down the province and on Newfoundland as well.

The appearances of the two species follow at least two ecogeographic rules. Glogers rule states that endothermic species (warm-blooded) will be darker colored in more humid environments. In terms of the amount of precipitation it gets, the Arctic tundra is a desert, so that the hoary is a lighter plumaged bird than the common fits.

The sides and back of the common are heavily streaked with brown. This is especially pronounced in the females. In hoary redpolls the females retain some streaking, but it is very faint in the males. David Sibley includes an illustration in his page for the hoary redpoll that shows its absence of streaking under the tails as well. Common redpolls show variable amounts of streaking there.

The hoary also tends to be larger than the common, which conforms to Bergmanns rule: animals found in colder climates tend to have larger body mass than those from warmer climates. Common redpolls average 5.25 inches long, while hoaries average 5.5 inches, which isnt much of a difference. But the Greenland subspecies of the hoary averages a full 12% larger than the Canadian race. This constitutes what is called a cline, a gradual morphological transition across an environmental gradient. From the southern subspecies of the common redpoll in the taiga to the Greenland subspecies of the hoary, there is a tendency toward larger size in a progressively colder climate.

The cline does not apply as well to Glogers rule; the Greenland subspecies of the common is darker than its southern subspecies. But it works for the rest of the subspecies of both species.

The redpolls may even conform to Allens rule, which states that animals from colder climates tend to have a smaller surface-to-volume ratio (i.e., they are rounder) than those from warmer climates. This is often expressed as having smaller or shorter extremities. One of the characters used in the field to distinguish the hoary from the common (when they are both at your feeder in a single flock) is the smaller, shorter, straighter bill of the hoary.

On the New Hampshire Birds online forum, Fred Sladen of North Sutton recently shared a taxonomic discussion from the Illustrated Checklist of the Birds of the World (2016) that posits a third subspecies for the common redpoll. The so-called lesser redpoll is considered a longer- and slender-billed variant of [the] nominate with slightly longer wing and tail, and slightly deeper pink in adult male. To conform to the ecogeographic rules this subspecies should live somewhere warmer (longer bill, wings, and tail, Allens rule; and darker color, Glogers rule). In fact, it lives in northern Siberia, a colder, drier place than northern Europe, where the nominate species is found in Scandinavia, Finland, and the Baltic countries.

The redpolls were until recently in the genus Carduelis, a once species-rich taxon that molecular genetics has revealed to be what taxonomists call (when no one is listening) a garbage can group. Their DNA has shown the redpolls to be isolated branch of finches deserving of their own genus Acanthis, which is a name that was originally given to a Greek bird that now cannot be identified from contemporary descriptions of it.

The moral to this story is that when redpolls show up at your feeder, dont worry if you cant tell the species apart, never mind the subspecies. Their songs are the same and their ranges grade into one another, so its a mystery as to how they can tell each other apart.

Bill Chaisson has been a birdwatcher from the age of 10. He is a former managing editor of the Eagle Times and now works and lives in the town of Wilmot.

See the original post here:
Of a Feather: When cousins are two of a kind - eagletimes.com

Read More...

US rushes to catch up in the race to detect mutant viruses – WWLTV.com

February 7th, 2021 3:52 am

Scientists say their biggest issues have been an absence of national leadership and coordination, plus a lack of funding and supplies for overburdened laboratories.

NEW YORK Despite its world-class medical system and its vaunted Centers for Disease Control and Prevention, the U.S. fell behind in the race to detect dangerous coronavirus mutations. And it's only now beginning to catch up.

The problem has not been a shortage of technology or expertise. Rather, scientists say, its an absence of national leadership and coordination, plus a lack of funding and supplies for overburdened laboratories trying to juggle diagnostic testing with the hunt for genetic changes.

We have the brains. We have the tools. We have the instruments, said Ilhem Messaoudi, director of a virus research center at University of California, Irvine. "Its just a matter of supporting that effort."

Viruses mutate constantly. To stay ahead of the threat, scientists analyze samples, watching closely for mutations that might make the coronavirus more infectious or more deadly.

But such testing has been scattershot.

Less than 1% of positive specimens in the U.S. are being sequenced to determine whether they have worrisome mutations. Other countries do better Britain sequences about 10% meaning they can more quickly see threats coming at them. That gives them greater opportunity to slow or stop the problem, whether through more targeted contact tracing, possible adjustments to the vaccine, or public warnings.

CDC officials say variants have not driven recent surges in overall U.S. cases. But experts worry that what's happening with variants is not clear and say the nation should have been more aggressive about sequencing earlier in the epidemic that has now killed over 450,000 Americans.

If we had evidence it was changing, said Ohio State molecular biologist Dan Jones, "maybe people would've acted differently.

U.S. scientists have detected more than 500 cases of a variant first identified in Britain and expect it to become the cause of most of this countrys new infections in a matter of weeks. Another troubling variant tied to Brazil and a third discovered in South Africa were detected last week in the U.S. and also are expected to spread.

The British variant is more contagious and is believed to be more deadly than the original, while the South Africa one may render the vaccines somewhat less effective. The ultimate fear is that a variant resistant to existing vaccines and treatments could eventually emerge.

Potentially worrisome versions may form inside the U.S., too. This virus is mutating, and it doesn't care of it's in Idaho or South Africa," Messaoudi said.

But the true dimensions of the problem in the U.S. are not clear because of the relatively low level of sequencing.

You only see whats under the lamppost, said Kenny Beckman, director of the University of Minnesota Genomics Center, which started analyzing the viruss genetics last spring.

After the slow start, public health labs in at least 33 states are now doing genetic analysis to identify emerging coronavirus variants. Other states have formed partnerships with university or private labs to do the work. North Dakota, which began sequencing last week, was the most recent to start that work, according to the Association of Public Health Laboratories.

The CDC believes a minimum of 5,000 to 10,000 samples should be analyzed weekly in the U.S. to adequately monitor variants, said Gregory Armstrong, who oversees the agency's advanced molecular detection work. And it's only now that the nation is hitting that level, he acknowledged.

Still, it is a jumble of approaches: Some public health labs sequence every positive virus specimen. Some focus on samples from certain outbreaks or certain patients. Others randomly select samples to analyze.

On top of that, labs continue to have trouble getting needed supplies like pipette tips and chemicals used in both gene sequencing and diagnostic testing.

President Joe Biden, who inherited the setup from the Trump administration, is proposing a $1.9 trillion COVID-19 relief package that calls for boosting federal spending on sequencing of the virus, though the amount has not been detailed and other specifics have yet to be worked out.

Were 43rd in the world in genomic sequencing. Totally unacceptable, White House coronavirus response coordinator Jeff Zients said.

For more than five years, U.S. public health labs have been building up their ability to do genomic sequencing, thanks largely to a federal push to zero in on the sources of food poisoning outbreaks.

At the pandemic's outset, some labs began sequencing the coronavirus right away. The Minnesota Department of Health, for example, started doing so within weeks of its first COVID-19 cases in March, said Sara Vetter, an assistant lab director. That put us a step ahead, she said.

The CDC likewise worked with certain states to sequence close to 500 samples in April, and over a thousand samples in May and June.

But many labs didn't do the same especially those overburdened with ramping up coronavirus diagnostic testing. The CDC's Armstrong said that at the time, he couldn't justify telling labs to do more sequencing when they already had their hands full and there wasn't any evidence such analysis was needed.

Up until a month ago, it wasnt on the list of things that are urgently necessary. It was nice to have," said Trevor Bedford, ascientist at the Fred Hutchinson Cancer Research Center in Seattle. "There was definitely lack of federal resources assigned to doing exactly this.

At the same time, because of stay-at-home orders imposed during the outbreak, researchers at some labs were told not to go in to work, Messaoudi said.

Instead of having a call to arms, she said, they sent everyone home.

Over the summer, though, a group of scientistssounded the alarm about the state of genomic surveillance in the U.S. and began pushing for something more systematic.

In November, the CDC began to roll out a national program to more methodically pull and check specimens to better determine what strains are circulating. Then in December, the U.S. got a wake-up call when British researchers announced they had identified a variant that seems to spread more easily.

The CDC reacted by announcing its surveillance program would scale up to process 750 samples nationally per week. The agency also contracted with three companies LabCorp, Quest Diagnostics and Illumina to sequence thousands more each week. State labs are doing thousands of their own.

Meanwhile, the outbreak is almost certainly seeding more COVID-19 mutations.

Where it has free rein of the place, theres going to be significant variants that evolve, Scripps Research Institute scientist Dr. Eric Topol said. "The more genomic sequencing, the more we can stay ahead of the virus.

Read more:
US rushes to catch up in the race to detect mutant viruses - WWLTV.com

Read More...

Page 225«..1020..224225226227..230240..»


2025 © StemCell Therapy is proudly powered by WordPress
Entries (RSS) Comments (RSS) | Violinesth by Patrick